Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
OptimizeRx Corporation OPRX
$13.06
-$0.43 (-3.30%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
230869943.00000000
-
week52high
30.82
-
week52low
12.20
-
Revenue
62450156
-
P/E TTM
-24
-
Beta
0.99688500
-
EPS
-0.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Outperform | Outperform | 10 авг 2022 г. |
| RBC Capital | Outperform | Outperform | 10 авг 2022 г. |
| Piper Sandler | Neutral | Neutral | 10 авг 2022 г. |
| B. Riley Securities | Buy | Buy | 20 июл 2022 г. |
| SVB Leerink | Outperform | 15 июл 2022 г. | |
| Stifel | Buy | 01 ноя 2022 г. | |
| Stifel | Buy | 31 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| FEBBO WILLIAM J | D | 9628 | 9628 | 07 янв 2023 г. |
| FEBBO WILLIAM J | A | 471400 | 9628 | 07 янв 2023 г. |
| HALAS GUS D | D | 0 | 409 | 30 дек 2022 г. |
| HALAS GUS D | A | 65571 | 409 | 30 дек 2022 г. |
| Lang James Paul | D | 0 | 409 | 30 дек 2022 г. |
| Lang James Paul | A | 39403 | 409 | 30 дек 2022 г. |
| Spangler Patrick D | D | 0 | 409 | 30 дек 2022 г. |
| Spangler Patrick D | A | 16826 | 409 | 30 дек 2022 г. |
| Vos Ellen O'Connor | D | 0 | 409 | 30 дек 2022 г. |
| Vos Ellen O'Connor | A | 34133 | 409 | 30 дек 2022 г. |
Новостная лента
OptimizeRx Corporation (OPRX) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 мая 2023 г. в 22:44
OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Will Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial and Operating Officer Steve Silvestro - Chief Commercial Officer Marion Odence-Ford - General Counsel and Chief Compliance Officer Andrew D'Silva - Senior Vice President, Corporate Finance Conference Call Participants Jared Haase - William Blair Sean Dodge - RBC Stephanie Davis - SVB David Grossman - Stifel Neil Chatterji - B. Riley Max Michaels - Lake Street Capital Markets Operator Good afternoon, everyone.
OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
OptimizeRx Corp. (OPRX) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.01 per share a year ago.
OptimizeRx Has A Good Growth Path Ahead
Seeking Alpha
03 апр 2023 г. в 17:16
OptimizeRx Corporation is an interesting company with an investment thesis based on its ability to capture a large TAM, with customers being some of the largest pharma companies out there. The company's financial position is robust and they have been able to grow its top line at a notable and impressive rate recently.
OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock?
Zacks Investment Research
15 мар 2023 г. в 04:37
OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)
Benzinga
14 мар 2023 г. в 08:02
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.